Xarelto Bleeding Injuries and Death
The blood thinner Xarelto has been linked to serious injuries such as:
- internal or uncontrolled bleeding;
- brain hemorrhage;
- heart attack;
- pulmonary embolism;
- deep vein thrombosis;
- and even death.
If you or a loved one took Xarelto and suffered any of these serious injuries or died, you may be entitled to a cash award and compensation for medical expenses.
For a free confidential consultation, please call 1.800.988.8005 or submit an email inquiry above.
Xarelto belongs to a class of anticoagulants, or blood thinners, called direct factor Xa inhibitors. Xarelto (rivaroxaban) was first approved by the FDA in July 2011 and is manufactured by Bayer and Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals, and is marketed by Janssen Pharmaceuticals.
Xarelto is a prescription medicine with three primary uses:
- to reduce the risk of stroke and blood clots in people with atrial fibrillation;
- to treat deep vein thrombosis (blood clots in the legs) and pulmonary embolism (blood clots in the lungs), and to help reduce the risk of those conditions occurring again; and
- to reduce the risk of forming a blood clot in the legs and lungs of people who have just had knee or hip replacement surgery.
No Routine Blood Tests Required
While all blood thinners carry a risk of internal bleeding, Xarelto appears to be associated with a much greater risk than the manufacturers indicated in warnings provided to consumers and the medical community.
Xarelto was promoted as a convenient alternative to warfarin (Coumadin) because it did not require routine blood tests, close monitoring, or diet and lifestyle changes. However, recent studies indicate that patients with a high risk of bleeding would benefit from blood tests.
No Reversal Antidote Available
While doctors are able to reverse the effects of warfarin if bleeding occurs with vitamin K, Xarelto bleeding is often uncontrollable due to the lack of an approved reversal agent, thus increasing the risk of serious injury and death.
Blood Clot Related Injuries
Xarelto is often prescribed to prevent blood clots. Unfortunately, there is a growing amount of evidence linking it to an increased risk of blood clots.
According to a report published by the Institute for Safe Medicine Practices in October 2012, Xarelto was associated with 356 serious, disabling, or fatal injuries during the first quarter of 2012.
The investigators specifically warned about the risk of Xarelto blood clots: “The largest identifiable category was serious blood-clot-related injury — most frequently pulmonary embolism — the very events rivaroxaban is intended to prevent.”
Other Injuries May Include:
- Abdominal bleeding;
- Gastrointestinal bleeding;
- Kidney bleeding;
- Rectal bleeding.
Adverse Injury Reports
In 2011 and in 2012, adverse effects involving the use of Pradaxa, Xarelto and warfarin were the most frequently cited anticoagulants in reports to the FDA. A total of 151 deaths from Xarelto were reported.
In Germany alone, the number of side-effects from Xarelto has increased. In the first eight months of 2013, German regulators received 968 reports of side effects, including 72 deaths. This is a definite increase over 2012, when a total of 750 adverse reactions were reported, including 58 deaths, in Germany.
In May 2014, Boehringer Ingelheim, the maker of Pradaxa, a similar blood thinner, said it would pay $650 million to settle 4,000 U.S. lawsuits claiming injuries from severe and fatal bleeding as a result of taking the medication.
How We Can Help
Levy Konigsberg LLP is currently accepting Xarelto injury cases in all 50 states. If you or a loved one took Xarelto and suffered any of these serious injuries or died, you may be entitled to a cash award and compensation for medical expenses. For a free confidential consultation, please call 1.800.988.8005 or submit an email inquiry above.